Antitumour drug design: DNA-binding ligands, which inhibit the topoisomerase I

Pharmazie

Volumn 53, Issue 2, 1998, Pages 79-86

  Pindur, U ^a   Lemster, T ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

9 AMINOCAMPTOTHECIN; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; FAGARONINE; INTOPLICINE; IRINOTECAN; REBECCAMYCIN; SAINTOPIN; TOPOTECAN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; CYTOTOXICITY; DNA BINDING; DRUG DESIGN; ENZYME BINDING; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DNA TOPOISOMERASES, TYPE I; DRUG DESIGN; ENZYME INHIBITORS; HUMANS;

EID: 0031909310     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Waring, M. J.: Annu. Rev. Biochem. 50, 159 (1981)
2. Hurley, L. H.: J. Med. Chem. 32, 2027 (1989)
3. Krugh, T. R.: Curr. Opin. Struct. Biol. 4, 351 (1994)
4. Wang, J. C.: Annu. Rev. Biochem. 54, 665 (1985)
5. Chen, A. Y.; Liu, L. F.: Annu. Rev. Pharmacol. Toxicol. 34, 191 (1994)
6. Ralph, R. K.; Judd, W.; Pommier, Y.; Kohn, K. W.; in: Neidle, S.; Waring, M. J. (eds.): DNA topoisomerases in molecular aspects and anticancer drug-DNA interactions, Vol. 2, p. 1, Macmillan, London 1994
7. Kopka, M. L.; Larsen, T. A.; in: Probst, C. L.; Perun, T. J. (eds.): Netropsin and the lexitropsins, the search for sequence specific minor-groove-binding ligands, in nucleic acid targeted drug design, p. 303, Marcel Dekker, New York 1992
8. Chen, Y. H.; Lown, J. W.: J. Am. Chem. Soc. 116, 6995 (1994)
9. Lown, J. W.: J. Mol. Recognit. 7, 79 (1994)
10. Pindur, U.; Fischer, G.: Curr. Med. Chem. 3, 325 (1996)
11. Bourdouxhe-Houssiaux, C.; Colson, P.; Houssier, C.; Waring, M. J.; Bailly, C.: Biochemistry 35, 4251 (1996)
12. Metz, G.: Pharm. Ztg. 140, 4232 (1995)
13. Potmesil, M.; Kohn, K. W. (Eds.): DNA topoisomerase in cancer, Oxford University Press, New York 1991
14. Pindur, U.; Sattler, K.; Haber, M. J.: Chem. Educ. 70, 263 (1993)
15. Neidle, S.; in: Bedell, C. R. (ed.): The design of drugs to macromolecular targets, p. 173, John Wiley & Sons Ltd., Chichester 1992
16. René, B.; Posse, P.; Khelifa, T.; Jaquemin-Bablon, A.; Bailly, C.: Molec. Pharmacol. 49, 343 (1996)
17. Geierstanger, B. H.; Mrksich, M.; Dervan, P. B.; Wemmer, D. E.: Science 266, 646 (1994)
18. Su, T.-L.; Chen, T.-C.; Watnabe, R. A.: Cur. Opin. Then Patents 1121 (1992)
19. Pommier, Y.; Tanizawa, A.; in: Hickman, J. A.; Tritton, T. R. (eds.): Cancer chemotherapy, p. 214, Blackwell Scientific Publication, Oxford 1993
20. Bailly, C.; Hennichart, J. P.: Bioconjugate Chemistry 2, 379 (1991)
21. Voet, D.; Voet, J. G.: Biochemistry, John Wiley & Sons Ltd., Chichester 1990
22. Wang, J. C.: J. Biol. Chem. 266, 6659 (1991)
23. Insaf, S. S.; Danks, M. K.; Witiak, D. T.: Curr. Med. Chem. 3, 437 (1996)
24. Giovanella, B.; Stehlin, J. S.; Wall, M. E.; Wani, M. C.; Nicholas, A. W.; Liu, L. F.; Silber, R.; Potmesil, M.: Science 246, 1046 (1989)
25. Potmesil, M.; Hsiang, Y.-H.; Silber, R.: Cancer Res. 48, 3537 (1988)
26. Hsiang, Y.-H.; Liu, L. F.: Cancer Res. 48, 1722 (1988)
27. Hecht, S. M.: J. Nat. Prod. 55, 401 (1992)
28. Pommier, Y. et al.; in: Andoh, T. et al. (eds.): Molecular biology of DNA topoisomerases and its application to chemotherapy, p. 215, CRC Press, Boca Raton 1993
29. Capranico, G.; Zunino, F.; in: Arcamone, F. (ed.): Anti-cancer agents, Vol. 1, p. 1, 1995
30. Liu, L. F.: Ann. Rev. Biochem. 58, 351 (1989)
31. Baur, R.: Pharm. Ztg. 140, 1929 (1995)
32. Hertzberg, R. R.; Busby, R. W.; Caranta, M. J.; Holden, K. G.; Johnson, R. K.; Hecht, S. M.; Kingsbury, W. D.: J. Biol. Chem. 265, 19287 (1990)
33. Sinha, B. K.: Drugs 49, 11 (1995)
34. Hsiang, Y.-H.; Hertzberg, R. R.; Hecht, S.; Liu, L. F.: J. Biol. Chem. 260, 14873 (1985)
35. Crow, R. T.: J. Med. Chem. 37, 3191 (1994)
36. Luzzio, M. J.: J. Med. Chem. 38, 395 (1995)
37. Eckardt, J. R.; Burris, H. A.; Rothenberg, M. L.: Contemp. Oncol. 3, 47 (1993)
38. Slichenmyer, W. J.; Rowinsky, E. K.; Dorehower, R. C.: J. Natl. Cancer Inst. 85, 271 (1993)
39. Dahut, W.; Brillhart, C.; Takimoto, C.: ASCO, May 124, Dallas, Texas, USA 1994
40. Bornkessel, B.: Med. Mo. Pharm. 20, 114 (1997)
41. Hendricks, C. B.; Rowinsky, E. K.; Grochow, L. B.: Canc. Res. 52, 2268 (1992)
42. Ohno, R.; Okado, K.; Masaoka, T.: J. Clin. Oncol. 8, 1907 (1990)
43. Kragh Larsen, A.: Biochem. Pharmacol. 46, 1403 (1993)
44. Rion, J.-F.: Canc. Res. 53, 5987 (1993)
45. Leteurtre, F. J.: Biol. Chem. 269, 28, 702 (1994)
46. Chen, A. Y.; Yu, C.; Gatto, B.; Liu, L. F.: Proc. Natl. Acad. Sci. USA 90, 8131 (1993)
47. Bush, J. A.; Long, B. H.; Bradner, W. T.: Antibiotics 40, 668 (1987)
48. Gribble, G. W.: Berthel, S. J.: A survey of indole[2,3-a]carbazole alkaloids and related natural products; in: Studies in Natural Products Chemistry 12, 365 (1993)
49. Krishnan, B. S.; Moore, M. E.; Lavoie, C. P.; Long, B. H.; Dalterio, R. A.: J. Biomol. Struct. and Dynamics 12, 625 (1994)
50. Yoshinari, Y.: Canc. Res. 55, 1310 (1995); for recent results of topoisomerase I inhibitors of these series see: Anizon, F. et al.: J. Med. Chem. 40, 3456 (1997)
51. Yoshinari, Y.: Canc. Res. 55, 1310 (1995); for recent results of topoisomerase I inhibitors of these series see: Anizon, F. et al.: J. Med. Chem. 40, 3456 (1997)
52. Mortensen, U. H.; Stevnsner, T.; Krogh, S.; Olesen, K.; Westergaard, O.; Bonven, B. J.: Nucleic Acid Res. 18, 1983 (1990)
53. Sun, Q.; Gatto, B.; Yu, C.; Liu, A.; Liu, L. F.; LaVoie, E. J.: Bioorg. Med. Chem. Lett. 24, 2871 (1994)
54. Mong, S.; Strong, J. E.; Bush, J. A.; Crooke, S. T.: Chemother. 16, 398 (1979)
55. Hartenstein, J. H.; Aranda, J.; Barth, H.; Betche, H. J.; Kleinschroth, J.; Reck, R.; Rudolph, C.; Trostmann, U.; Schächtele, C.; in: Perspectives in medicinal chemistry, B. 2, inhibitors of other enzymes, chapter 8, p. 99, Verlag Helvetica Chimica Acta Basel, VCH, New York 1993